Trials / Completed
CompletedNCT00310466
Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever
A Multicentre, Randomised, Double-blind, Placebo-controlled Parallel Group Clinical Trial to Investigate the Efficacy and Safety of Specific Sublingual Immunotherapy With SLITone Birch in Patients With Seasonal Birch Pollen Induced Rhinoconjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 226 (actual)
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The trial is performed to assess the efficacy and safety of SLIT One birch for treatment of birch pollen induced allergy
Detailed description
Daily rhinoconjunctivits symptom and medication scores from patient diaries, adverse events
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Sublingual immunotherapy | once daily intake of sublingual drops |
| BIOLOGICAL | Placebo | once daily intake of sublingual drops |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2006-08-01
- Completion
- 2007-01-01
- First posted
- 2006-04-04
- Last updated
- 2013-05-14
- Results posted
- 2009-08-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00310466. Inclusion in this directory is not an endorsement.